Published in Mol Cell Proteomics on January 12, 2004
Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding. Chem Rev (2008) 2.27
The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med (2005) 1.55
MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response. PLoS One (2012) 0.93
MHC class I antigen presentation and implications for developing a new generation of therapeutic vaccines. Ther Adv Vaccines (2014) 0.91
Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients. Mol Cell Proteomics (2012) 0.85
Posttranslational modifications of proteins in type 1 diabetes: the next step in finding the cure? Diabetes (2012) 0.84
Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells. Proteomics (2011) 0.81
A novel strategy for the targeted analysis of protein and peptide metabolites. Proteomics (2010) 0.80
Contributions to our understanding of T cell physiology through unveiling the T cell proteome. Clin Exp Immunol (2007) 0.80
Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol (2014) 0.78
Proteomics Tracing the Footsteps of Infectious Disease. Mol Cell Proteomics (2017) 0.78
Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications. Future Virol (2012) 0.78
T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association. J Immunol (2014) 0.77
Stable isotope shifted matrices enable the use of low mass ion precursor scanning for targeted metabolite identification. Proteome Sci (2011) 0.75
The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure (2001) 2.41
An apparatus for simultaneous manual solid-phase synthesis of multiple peptide analogs. Anal Biochem (1984) 1.29
Characterization of GMP-140 (P-selectin) as a circulating plasma protein. J Exp Med (1992) 1.28
Quantitative and qualitative influences of tapasin on the class I peptide repertoire. J Immunol (2001) 1.27
Characterization of protease cleavage sites involved in the formation of the envelope glycoprotein and three non-structural proteins of dengue virus type 2, New Guinea C strain. J Gen Virol (1987) 1.26
Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex. Biochemistry (1989) 1.18
The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse. J Biol Chem (1993) 1.13
Characterization of human platelet GMP-140 as a heparin-binding protein. Biochem Biophys Res Commun (1989) 1.07
Tapasin-mediated retention and optimization of peptide ligands during the assembly of class I molecules. J Immunol (2000) 1.04
Cloning, expression, and crystallization of the fusion protein of Newcastle disease virus. Virology (2001) 1.02
The disulfide bonds in the C-terminal domains of the human insulin receptor ectodomain. J Biol Chem (1997) 1.02
Identification of disulfide-linked peptides by isotope profiles produced by peptic digestion of proteins in 50% (18)O water. Protein Sci (2001) 1.01
Protransglutaminase E from guinea pig skin. Isolation and partial characterization. J Biol Chem (1990) 1.01
Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. J Biol Chem (1984) 1.00
Characterization of pathotype-specific epitopes of newcastle disease virus fusion glycoproteins by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and post-source decay sequencing. J Mass Spectrom (1998) 0.99
Structural features of glutamine substrates for human plasma factor XIIIa (activated blood coagulation factor XIII). J Biol Chem (1980) 0.95
Covalent cross-linking of a photoactive derivative of calcitonin to human breast cancer cell receptors. J Biol Chem (1982) 0.89
Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. J Biol Chem (1981) 0.88
Fluorescent labeling of cysteinyl residues to facilitate electrophoretic isolation of proteins suitable for amino-terminal sequence analysis. Anal Biochem (1987) 0.87
Determination of the disulfide bond arrangement of Newcastle disease virus hemagglutinin neuraminidase. Correlation with a beta-sheet propeller structural fold predicted for paramyxoviridae attachment proteins. J Biol Chem (2000) 0.87
Transglutaminase amine substrates for photochemical labeling and cleavable cross-linking of proteins. J Biol Chem (1980) 0.86
Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies. J Gen Virol (1993) 0.85
Pathotyping isolates of Newcastle disease virus using antipeptide antibodies to pathotype-specific regions of their fusion and hemagglutinin-neuraminidase proteins. Arch Virol (1999) 0.83
Avoidance of self-reactivity results in skewed CTL responses to rare components of synthetic immunogens. J Immunol (1998) 0.81
The use of post-source decay in matrix-assisted laser desorption/ionisation mass spectrometry to delineate T cell determinants. J Immunol Methods (2001) 0.81
The structure of human thrombin in relation to autolytic degradation. Biochim Biophys Acta (1976) 0.80
The calcitonin receptor on T 47D breast cancer cells. Evidence for glycosylation. Biochem J (1983) 0.80
Complete amino acid sequence of a new murine T-cell growth factor P40. Eur J Biochem (1989) 0.79
Isolation and characterization of multiple forms of human thrombin. Thromb Res (1974) 0.78
Photoaffinity labeling of the calcitonin receptor. Pharmacol Ther (1987) 0.76
Characterization of field isolates of Newcastle disease virus using antipeptide antibodies. Avian Dis (1994) 0.76
Inhibition of human thrombin assessed with different substrates and inhibitors. Characterization of fibrinopeptide binding interaction. Biochim Biophys Acta (1975) 0.75
Synthetic glutamine peptides as substrates for the kinetic determination of blood coagulation factor XIII. Clin Chem (1985) 0.75
Human fibrinopeptides as antithrombins. Thromb Diath Haemorrh (1973) 0.75
Fibrinolysis and haemostasis. Aust N Z J Med (1972) 0.75
Studies on the structure and subunit composition of human antihaemophilic factor. Thromb Res (1978) 0.75
Oligosaccharide characterization and quantitation using 1-phenyl-3-methyl-5-pyrazolone derivatization and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem (1997) 0.75